Patents by Inventor Mark Anthony Kerry

Mark Anthony Kerry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIVIRAL COMPOUNDS
    Publication number: 20220356148
    Abstract: The present invention relates to novel compounds of general Formula II: wherein the groups X, and R1 to R4 have the meanings given in the description, to a process for preparing these compounds and to their use for treating, preventing or ameliorating viral infections and diseases which are associated with PLA2G16.
    Type: Application
    Filed: June 28, 2021
    Publication date: November 10, 2022
    Inventors: Wolfgang Fischl, Mark Whittaker, Christopher John Yarnold, Jean-Francois Pons, Mark Anthony Kerry, Patricia Leonie Amouzegh, Inaki Morao, Peter Neville Ingram, Ewa Iwona Chudyk
  • Antiviral compounds
    Patent number: 11180479
    Abstract: The present invention relates to novel compounds of general formula (I) wherein R1 to R4 and n have the meanings given in the description and claims, process for preparing these compounds and their use as for treating, preventing or ameliorating viral infections and their use for treating, preventing or ameliorating diseases which are associated with PLA2G16.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: November 23, 2021
    Assignee: HAPLOGEN GMBH
    Inventors: Wolfgang Fischl, Christopher John Yarnold, Patricia Leonie Amouzegh, Kevin Thewlis, Jon Shepherd, Mark Anthony Kerry
  • Antiviral compounds
    Patent number: 11091428
    Abstract: The present invention relates to novel compounds of general formula (I) wherein the groups X, and R1 to R4 have the meanings given in the description and claims, process for preparing these compounds and their use as for treating, preventing or ameliorating viral infections and their use for treating, preventing or ameliorating diseases which are associated with PLA2G16.
    Type: Grant
    Filed: September 12, 2017
    Date of Patent: August 17, 2021
    Assignee: HAPLOGEN GMBH
    Inventors: Wolfgang Fischl, Mark Whittaker, Christopher John Yarnold, Jean-Francois Pons, Mark Anthony Kerry, Patricia Leonie Amouzegh, Inaki Morao, Peter Neville Ingram, Ewa Iwona Chudyk
  • ANTIVIRAL COMPOUNDS
    Publication number: 20200239446
    Abstract: The present invention relates to novel compounds of general formula (I) wherein R1 to R4 and n have the meanings given in the description and claims, process for preparing these compounds and their use as for treating, preventing or ameliorating viral infections and their use for treating, preventing or ameliorating diseases which are associated with PLA2G16.
    Type: Application
    Filed: October 5, 2018
    Publication date: July 30, 2020
    Inventors: Wolfgang FISCHL, Christopher John YARNOLD, Patricia Leonie AMOUZEGH, Kevin THEWLIS, Jon SHEPHERD, Mark Anthony KERRY
  • ANTIVIRAL COMPOUNDS
    Publication number: 20190225575
    Abstract: The present invention relates to novel compounds of general formula (I) wherein the groups X, and R1 to R4 have the meanings given in the description and claims, process for preparing these compounds and their use as for treating, preventing or ameliorating viral infections and their use for treating, preventing or ameliorating diseases which are associated with PLA2G16.
    Type: Application
    Filed: September 12, 2017
    Publication date: July 25, 2019
    Inventors: Wolfgang Fischl, Mark Whittaker, Christopher John Yarnold, Jean-Francois Pons, Mark Anthony Kerry, Patricia Leonie Amouzegh, Inaki Morao, Peter Neville Ingram, Ewa Iwona Chudyk